Kalashnikov Maxim, Lee Jean C, Sauer-Budge Alexis F
Center for Manufacturing Innovation, Fraunhofer USA, Brookline, MA 02446, USA.
Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Diagnostics (Basel). 2018 Apr 17;8(2):24. doi: 10.3390/diagnostics8020024.
The rapid evolution of antibiotic resistance in bacterial pathogens is driving the development of innovative, rapid antibiotic susceptibility testing (AST) tools as a way to provide more targeted and timely antibiotic treatment. We have previously presented a stress-based microfluidic method for the rapid determination of antibiotic susceptibility in methicillin-susceptible (MSSA) and methicillin-resistant (MRSA). In this method, stress is used to potentiate the action of antibiotics, and cell death is measured as a proxy for susceptibility. The method allows antibiotic susceptibility to be determined within an hour from the start of the antibiotic introduction. However, the relatively low dynamic range of the signal (2–10% cell response) even with high antibiotic concentrations (10–50 µg/mL) left room for the method’s optimization. We have conducted studies in which we varied the flow patterns, the media composition, and the antibiotic concentration to increase the cell death response and concordantly decrease the required antibiotic concentration down to 1–3 µg/mL, in accordance with the Clinical and Laboratory Standards Institute’s (CLSI) guidelines for AST breakpoint concentrations.
细菌病原体中抗生素耐药性的快速演变推动了创新型快速抗生素敏感性测试(AST)工具的开发,以此作为提供更具针对性和及时性抗生素治疗的一种方式。我们之前提出了一种基于应激的微流控方法,用于快速测定甲氧西林敏感(MSSA)和耐甲氧西林(MRSA)菌株的抗生素敏感性。在该方法中,应激被用于增强抗生素的作用,细胞死亡被用作敏感性的替代指标进行测量。该方法能够在引入抗生素开始后的一小时内确定抗生素敏感性。然而,即便使用高浓度抗生素(10 - 50μg/mL),信号的动态范围相对较低(2% - 10%细胞反应),这为该方法的优化留下了空间。我们开展了多项研究,在研究中改变了流动模式、培养基成分和抗生素浓度,以增加细胞死亡反应,并相应地将所需抗生素浓度降低至1 - 3μg/mL,这符合临床和实验室标准协会(CLSI)关于AST断点浓度的指南。